Guide · Compliance and validation

Machine Features That Reduce USFDA 483 Observations

By the Hello Pharma Editorial Team · Last updated 19 November 2026 · 3 min read

Short answer

Equipment-related FDA observations cluster around cleaning and maintenance (211.67), computer controls and data integrity (211.68), equipment design and location (211.63), aseptic processing (211.113) and labelling controls. The machine features that help most are cleanable, drainable designs with wash-in-place; built-in maintenance and calibration reminders; individual user accounts with non-editable audit trails; barrier technology and fewer interventions for sterile lines; and vision-verified labelling with secure rejects. Features reduce risk only when backed by procedures and review.

483 themes mapped to features

Theme (21 CFR)Typical findingMachine feature that helps
211.67 cleaning and maintenanceResidues, missed maintenance, inadequate cleaning proceduresPolished, drainable, crevice-free design; wash-in-place; maintenance counters and alerts
211.68(b) computer controlsShared logins, disabled audit trails, unauthorised changesIndividual accounts, role-based access, protected audit trails, data transfer to server
211.68(a) calibrationInstruments out of calibrationCalibration due reminders, interlocks on expired calibration
211.63 design and locationEquipment unsuitable or hard to clean in placeThrough-wall design, correct sizing, cleanable layout
211.113(b) aseptic processingInterventions, poor airflowRABS or isolator, first air design, automated loading
211.122 to 211.130 labellingMix-ups, missing verificationLabel identity codes, OCR/OCV, verified rejects, reconciliation counts
211.192 investigationsIncomplete deviation investigationsEvent logs, alarm histories and batch data that support root cause analysis

In fiscal 2025 analyses, 211.67(a), 211.68(b) and 211.63 each accounted for roughly 3% of drug observations.

Why features alone are not enough

Inspectors look for working systems: a perfect audit trail that nobody reviews still leads to findings. Pair every feature with an SOP, training and periodic review, and record that the review happened. Warning letters frequently note that responses lacked a retrospective assessment of data integrity impact, not just a technical fix.

Specification tips

  1. Map past findings at your site to machine requirements in the URS.
  2. Test data integrity and reject features at FAT; see FAT and SAT.
  3. Choose designs that make cleaning visible and verifiable.
  4. Integrate machine data with site systems for review.

Related: equipment upgrades that fix audit findings and audit trail features.

Companies listed in the Hello Pharma supplier directory

The Hello Pharma supplier directory lists 51 companies relevant to this guide, grouped below by machine type or category. Each name links to the company's directory entry, with a description, technologies, location and website. Companies confirmed against their websites or public listings appear first in each group.

Inclusion is not an endorsement or ranking. Many categories are inferred from company names and segments, so confirm capabilities, approvals and service reach directly with each supplier. Search all 1,232 companies.

Pharma software (8)

Caliber Technologies; Catalogic Technologies LLP; ChemRobotics Private Limited; KAN-THT (India) Pvt. Ltd; Progen ERP Systems (P) Ltd.; Sarjen Systems Pvt Ltd; Sundaram Technologies; ValGenesis (India) Private Limited.

Open the full entries: Automation, inspection and serialization list filtered to pharma software

Vision inspection (14)

Ace Technologies & Packaging Systems Pvt Ltd; ACG Worldwide Solid Dosage Consumables and Machinery; Brio Pharma Technologies Pvt Ltd; Brothers Pharmamach (I) Pvt Ltd; Compromec; CVC Technologies; Jagson Engineers; Jekson; Parle Global Technologies Pvt. Ltd.; Salesworth Synergies LLP; Cognex Sensors India Pvt. Ltd.; ImageProVision Technology; Inos Technologies Pvt. Ltd.; Utopia Optovision Pvt. Ltd.

Open the full entries: Automation, inspection and serialization list filtered to vision inspection · Packaging machinery list filtered to vision inspection · Sterile, injectable and liquid equipment list filtered to vision inspection · Oral solid dosage equipment list filtered to vision inspection

Automation and controls (29)

Accupack Engineering Pvt Ltd; Adam Fabriwerk; A.S. Automations; Appidi Technologies Pvt. Ltd.; Avcon Controls Pvt. Ltd.; B&R Industrial Automation Pvt. Ltd.; B.D. Industries; Crystal Automation Pvt. Ltd; Electronics Devices Worldwide Pvt Ltd; Elektrocraft (India) Pvt. Ltd.; Hilda Automation; Inline Technologies; Jay Instruments & Systems Pvt Ltd; Kesar Control Systems; MICROCON; Millenia Technologies; Mitsubishi Electric India Pvt Ltd.; Ngen Controls System; Nord Drivesystems Pvt Ltd; P.M Electro Auto Pvt. Ltd; PRETECH Automation Pvt. Ltd.; Protech Technologies Pvt. Ltd.; Radix Electrosystems Pvt. Ltd.; Saksham Technologies Pvt. Ltd.; Shubham Automation Pvt. Ltd.; Sierra Instrumentation & Controls; Staubli Tec Systems India Pvt Ltd; Sunjay Technologies Pvt Ltd; Toshniwal Instrument Mfg.Pvt.Ltd.

Open the full entries: Automation, inspection and serialization list filtered to automation and controls · Packaging machinery list filtered to automation and controls · Components and spares list filtered to automation and controls · Sterile, injectable and liquid equipment list filtered to automation and controls

Frequently asked questions

Which equipment issues does FDA cite most often?

Cleaning and maintenance (211.67), computer system controls (211.68) and equipment design or location (211.63) are among the most frequent equipment-related observations.

Can a machine prevent data integrity findings?

It can provide controls such as individual logins and protected audit trails, but procedures, training and review are needed too.

Do sterile lines attract specific 483s?

Yes. Aseptic interventions, airflow, environmental monitoring and media fills are common themes, where barrier technology helps.

How should features be specified?

In the URS, traced to tests at FAT, SAT and OQ, with procedures written before go-live.

Related guides

Sources

  1. FY 2025 FDA inspection observations, GMP Insiders
  2. Current FDA warning letters on IT topics, ECA Academy
  3. FDA issues warning letter due to severe violations of data integrity, ECA Academy
  4. 2024 trends in FDA observations for sterile drug manufacturers, Pharmaceutical Online
  5. 21 CFR Part 211, Subpart D Equipment, eCFR

This guide is general information to support decisions and is not engineering, validation or regulatory advice for a specific project.

Ready to read pharma differently?

Join the Hello Pharma community for editorial, intelligence and engineering reference from pharma manufacturing.